探索以LIF及LIFR為標靶的頭頸腫瘤免疫輔助治療潛能與抑制劑開發;Investigating the Potentiality of Targeting to Lif and Lifr for Adjuvant Immunotherapy in Head and Neck Cancers

NCUIR > college of Health Sciences and Technology > Department of Biomedical Sciences and Engineering > Research Project > Item 987654321/91047

Please use this identifier to cite or link to this item: http://ir.lib.ncu.edu.tw/handle/987654321/91047

Title:	探索以LIF及LIFR為標靶的頭頸腫瘤免疫輔助治療潛能與抑制劑開發;Investigating the Potentiality of Targeting to Lif and Lifr for Adjuvant Immunotherapy in Head and Neck Cancers
Authors:	劉淑貞;張凱評;余兆松
Contributors:	國立中央大學生醫科學與工程學系
Keywords:	頭頸癌;免疫治療;白血病抑制因子;免疫檢查點;標靶適體;適體;head and neck cancer;HNSCC;LIF;immune checkpoint;leukemia inhibitory factor;aptamer;SELEX
Date:	2023-07-17
Issue Date:	2023-07-18 13:52:27 (UTC+8)
Publisher:	國家科學及技術委員會
Abstract:	以適體為新穎小分子標靶檢測與治療應用在臨床和藥物開發方面的市場潛力大，針對合適標靶分子開發新型小分子抑制劑對惡性腫瘤治療具前瞻性與新穎性。本團隊研究關鍵標靶分子LIF/LIFR多年，針對LIF/LIFR的轉譯醫學應用已獲美、中、台醫療發明專利保護，對標的物的研發具競爭力。此外，對促進跨領域醫學產學合作有實質助益。
Relation:	財團法人國家實驗研究院科技政策研究與資訊中心
Appears in Collections:	[Department of Biomedical Sciences and Engineering ] Research Project

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	84	View/Open

社群 sharing